food and drug administration

menopause, FDA and Drug Administration

Digest more

· 16h · on MSN

New menopause drug without hormones approved by FDA. A doctor shares what to know.

Lynkuet works by blocking neurokinin-3 receptors, which help regulate body temperature and sleep.

· 3d · on MSN

US FDA approves Bayer's menopause relief drug

· 13h · on MSN

FDA approves non-hormonal medication for menopause symptoms

· 8h

Doctor explains new non-hormonal menopause drug for hot flashes

The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a non-hormonal option for treating hot flashes, common during menopause.

ConsumerAffairs · 14h

FDA approves a new non-hormonal fix for hot flashes

· 9h

FDA approves non-hormonal menopause drug to treat hot flashes, night sweats

· 16h

Bayer receives FDA approval for non-hormonal menopause therapy

“There is a need for more individualized approaches to menopause care, and Lynkuet addresses a significant gap in treatment options,” said Christine Roth, Bayer’s executive vice president of global p...

· 18h

New menopause drug to target hot flashes without hormones gets FDA approval

· 4h

New Hormone-Free Menopause Pill Cuts Hot Flashes by 55% and Improves Sleep

16h

Major cholesterol drug recalled over ‘failed dissolution’: What patients must know

Your prescription may be involved. The FDA explains why suddenly stopping your medication is more harmful than taking it.

FDA to fast-track nine experimental drugs under new Trump program

The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs.

11d

FDA unveils drugs to receive expedited review in support of 'national priorities'

The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at the agency

STAT

How the first nine drug companies won priority review vouchers from Marty Makary’s FDA

The winners include a gene therapy for a rare form of deafness, a drug for vaping addiction, and a generic antibiotic.

20h

Revolution Pancreatic Cancer Treatment Gets Orphan Drug Designation

The Food and Drug Administration granted orphan drug designation to Revolution Medicines' treatment for pancreatic cancer. The drug, called daraxonrasib, is being studied in a global phase three clinical trial and the company is planning to begin two more phase three trials for the drug.

FDA slows down on drug reviews, approvals amid Trump admin chaos

Amid the chaos of the Trump administration’s haphazard job cuts and a mass exodus of leadership, the Food and Drug Administration is experiencing a slowdown of drug reviews and approvals, according to an analysis reported by Stat News.

3don MSN

Over 140,000 bottles of popular cholesterol drug recalled

FDA announces Atorvastatin recall affecting over 140,000 bottles of cholesterol medication due to failed dissolution specs that could reduce effectiveness.

Recall Roundup: Pet food, makeup wipes, Ford vehicles lead the list

Foodynamics and Raw Bistro Pet Fare are recalling several products due to possible contamination. Salmonella can affect animals eating contaminated products and may become lethargic, have diarrhea or bloody diarrhea, fever, or vomiting, according to the FDA.

3don MSN

A liver transplant might save him — if he can get the drug he needs to stay alive long enough

A health insurance dispute is preventing a North Carolina man from getting a cancer drug his doctors say is necessary.

The Manila Times

Cellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma

CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma Patients Showed Extended Progression Free Survival and Overall Survival